 Antilymphocyte Serum
"Antilymphocyte Serum" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION.
| Descriptor ID |
D000961
|
| MeSH Number(s) |
A12.207.152.846.500.203 D12.776.124.486.485.114.573.203 D12.776.124.790.651.114.573.203 D12.776.377.715.548.114.573.203 D20.215.401.203
|
| Concept/Terms |
Antilymphocyte Serum- Antilymphocyte Serum
- Antilymphocyte Serums
- Serum, Antilymphocyte
- Serums, Antilymphocyte
Antilymphocyte Globulin- Antilymphocyte Globulin
- Antilymphocyte Globulins
- Globulin, Antilymphocyte
- Globulins, Antilymphocyte
Antithymoglobulin- Antithymoglobulin
- Antithymoglobulins
- Antithymocyte Globulin
- Antithymocyte Globulins
- Globulin, Antithymocyte
- Globulins, Antithymocyte
- Lymphocyte Immune Globulin, Anti-Thymocyte Globulin
- Lymphocyte Immune Globulin, Anti Thymocyte Globulin
- Anti-Thymocyte Globulin
- Anti Thymocyte Globulin
- Anti-Thymocyte Globulins
- Globulin, Anti-Thymocyte
- Globulins, Anti-Thymocyte
Antilymphoblast Globulins- Antilymphoblast Globulins
- Antilymphoblast Globulin
- Globulin, Antilymphoblast
- Globulins, Antilymphoblast
Antilymphocyte Immunoglobulin- Antilymphocyte Immunoglobulin
- Antilymphocyte Immunoglobulins
- Immunoglobulin, Antilymphocyte
- Immunoglobulins, Antilymphocyte
|
Below are MeSH descriptors whose meaning is more general than "Antilymphocyte Serum".
Below are MeSH descriptors whose meaning is more specific than "Antilymphocyte Serum".
This graph shows the total number of publications written about "Antilymphocyte Serum" by people in this website by year, and whether "Antilymphocyte Serum" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 1 | 1 | 2 | | 1981 | 1 | 2 | 3 | | 1982 | 0 | 3 | 3 | | 1983 | 0 | 4 | 4 | | 1984 | 0 | 1 | 1 | | 1987 | 1 | 2 | 3 | | 1988 | 0 | 1 | 1 | | 1989 | 0 | 2 | 2 | | 1990 | 0 | 1 | 1 | | 1992 | 0 | 1 | 1 | | 1994 | 0 | 1 | 1 | | 1995 | 1 | 3 | 4 | | 1996 | 2 | 2 | 4 | | 1997 | 3 | 4 | 7 | | 1998 | 0 | 1 | 1 | | 1999 | 0 | 1 | 1 | | 2001 | 5 | 0 | 5 | | 2003 | 2 | 1 | 3 | | 2004 | 1 | 2 | 3 | | 2005 | 2 | 4 | 6 | | 2006 | 2 | 0 | 2 | | 2008 | 0 | 1 | 1 | | 2015 | 1 | 0 | 1 | | 2017 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Antilymphocyte Serum" by people in Profiles.
-
Gooptu M, Kim HT, Chen YB, Rybka W, Artz A, Boyer M, Johnston L, McGuirk J, Shea TC, Jagasia M, Shaughnessy PJ, Reynolds CG, Fields M, Alyea EP, Ho VT, Glavin F, Dipersio JF, Westervelt P, Ritz J, Soiffer RJ. Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial. Biol Blood Marrow Transplant. 2018 11; 24(11):2216-2223.
-
Soiffer RJ, Kim HT, McGuirk J, Horwitz ME, Johnston L, Patnaik MM, Rybka W, Artz A, Porter DL, Shea TC, Boyer MW, Maziarz RT, Shaughnessy PJ, Gergis U, Safah H, Reshef R, DiPersio JF, Stiff PJ, Vusirikala M, Szer J, Holter J, Levine JD, Martin PJ, Pidala JA, Lewis ID, Ho VT, Alyea EP, Ritz J, Glavin F, Westervelt P, Jagasia MH, Chen YB. Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation. J Clin Oncol. 2017 Dec 20; 35(36):4003-4011.
-
Echenique IA, Angarone MP, Gordon RA, Rich J, Anderson AS, McGee EC, Abicht TO, Kang J, Stosor V. Invasive fungal infection after heart transplantation: A 7-year, single-center experience. Transpl Infect Dis. 2017 Feb; 19(1).
-
Segovia J, van Besien K. Antithymocyte globulin for graft-versus-host disease prophylaxis: mistakenly maligned. Leuk Lymphoma. 2015 Apr; 56(4):841-2.
-
Lyons P, Castillo J, Potter L, Fedson S. Serum sickness after treatment with rabbit antithymocyte globulin in a heart transplant recipient with previous rabbit exposure. Transplant Proc. 2015 Jan-Feb; 47(1):198-200.
-
Thrush PT, Gossett JG, Costello JM, Matthews KL, Nubani R, Bhagat H, Backer CL, Pahl E. Role for immune monitoring to tailor induction prophylaxis in pediatric heart recipients. Pediatr Transplant. 2014 Feb; 18(1):79-86.
-
Schadde E, D'Alessandro AM, Knechtle SJ, Odorico J, Becker Y, Pirsch J, Sollinger H, Fernandez LA. Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death. Transpl Int. 2008 Jul; 21(7):625-36.
-
Pascual J, Mezrich JD, Djamali A, Leverson G, Chin LT, Torrealba J, Bloom D, Voss B, Becker BN, Knechtle SJ, Sollinger HW, Pirsch JD, Samaniego MD. Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation. Transplantation. 2007 Jun 15; 83(11):1429-34.
-
Josephson MA. Rabbit antithymocyte globulin or basiliximab for induction therapy? N Engl J Med. 2006 Nov 09; 355(19):2033-5.
-
Nair S, Loss GE, Cohen AJ, Eason JD. Induction with rabbit antithymocyte globulin versus induction with corticosteroids in liver transplantation: impact on recurrent hepatitis C virus infection. Transplantation. 2006 Feb 27; 81(4):620-2.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|